Rick Wise
Stock Analyst at Stifel
(2.32)
# 869
Out of 5,271 analysts
235
Total ratings
58.82%
Success rate
19.79%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LivaNova | Maintains: Buy | 72 60 | 41.74 | 43.75% | 6 | Feb 26, 2025 | |
Artivion | Maintains: Buy | 33 30 | 25.18 | 19.14% | 6 | Feb 25, 2025 | |
AtriCure | Maintains: Strong Buy | 36 48 | 38.95 | 23.23% | 12 | Feb 13, 2025 | |
Boston Scientific | Maintains: Strong Buy | 115 120 | 104.8 | 14.5% | 11 | Feb 10, 2025 | |
Conmed | Maintains: Strong Buy | 72 75 | 58.28 | 28.69% | 10 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 75 90 | 71.41 | 26.03% | 16 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 400 440 | 394.58 | 11.51% | 13 | Jan 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 130 138 | 105.33 | 31.02% | 14 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 170 155 | 167.03 | -7.2% | 5 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 130 135 | 140.22 | -3.72% | 15 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 525 610 | 567.1 | 7.56% | 15 | Dec 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 170 190 | 190.3 | -0.16% | 14 | Nov 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 46 38 | 34.85 | 9.04% | 7 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 7 8 | 8.71 | -8.15% | 8 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 17 16 | 8.27 | 93.47% | 4 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 82 | 80.14 | 2.32% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 100 102 | 86.44 | 18% | 2 | Sep 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 85 87 | 94.02 | -7.47% | 10 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 270 280 | 228.3 | 22.65% | 5 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 23 28 | n/a | n/a | 10 | Jul 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 9 12 | 6.97 | 72.17% | 3 | Jul 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 59 75 | 91.85 | -18.35% | 1 | Apr 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 32 34 | 23.18 | 46.68% | 5 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 17 24 | 20.75 | 15.66% | 6 | Feb 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 26 6 | 0.68 | 782.35% | 4 | Oct 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 25 | 15.1 | 65.56% | 4 | Jun 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 2 | n/a | n/a | 2 | Apr 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 103 112 | 47.07 | 137.94% | 5 | Oct 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 30 | n/a | n/a | 5 | Feb 25, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 58 67 | n/a | n/a | 4 | Jun 22, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 50 | n/a | n/a | 7 | May 21, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | n/a | n/a | 2 | May 4, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 84 85 | n/a | n/a | 2 | Nov 6, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 49 52 | n/a | n/a | 1 | Oct 30, 2017 |